I now have comprehensive content across multiple major textbooks. Let me compile the full, detailed response:
Management of Osteomyelitis
Classification
Osteomyelitis is classified by several overlapping systems, which guide management:
| Criterion | Categories |
|---|
| Duration | Acute · Subacute · Chronic |
| Pathogenesis | Hematogenous · Contiguous (post-traumatic/surgical) · Vascular insufficiency/neuropathy |
| Location | Long bones · Vertebral column · Periarticular / flat bones |
| Foreign material | Implant-associated vs. native bone |
The key therapeutic decision is whether bone necrosis (sequestrum) is present: acute osteomyelitis without bone necrosis can generally be treated with antibiotics alone; chronic osteomyelitis requires combined antibiotic therapy + debridement surgery. — Harrison's, 22e
Cierny-Mader Staging (Chronic Osteomyelitis)
Anatomic type:
- Type I — Medullary
- Type II — Superficial
- Type III — Localized
- Type IV — Diffuse
Host class:
| Class | Description |
|---|
| A | Normal host |
| BL (local) | Compromised vascularity (arterial disease, venous stasis, irradiation, scarring, smoking) |
| BS (systemic) | Compromised immune system (diabetes, malnutrition, ESRD, malignancy, HIV, immunosuppression, DMARDs) |
| BL/S | Combined local and systemic compromise |
| C | Treatment risks outweigh benefits |
— Miller's Review of Orthopaedics, 9e
General Principles of Treatment
Goal: Contain infection before bone necrosis occurs — cure rates fall dramatically once necrosis develops.
Initial priorities:
- Adequate IV access and fluid resuscitation if septic
- Blood cultures × 2 before starting antibiotics (in clinically stable patients)
- Tissue/bone culture before committing to a prolonged antibiotic course
- Multidisciplinary involvement: Infectious disease + Orthopaedic/Surgical team
Antibiotic principles:
- Must penetrate bone/synovial membrane — most antibiotics do, but penicillin and metronidazole penetrate bone poorly
- Must be bactericidal against the offending organism
- Chemical stability at low pH of infected tissue is important — cephalosporins are stable; aminoglycosides lose bactericidal activity in acidic environments
- Target serum level ≥ 8× MIC
Acute Osteomyelitis
Medical Management (Antibiotics)
Antibiotic therapy alone is appropriate for:
- Asymptomatic osteomyelitis incidentally discovered
- Hematogenous infection by sensitive organisms or fungi
- Vertebral osteomyelitis caused by sensitive pathogens
Standard duration: 4–6 weeks (6 weeks is the widely used benchmark)
Empiric IV therapy (ED initiation):
- Oxacillin or Nafcillin (penicillinase-resistant penicillin) — first-line for MSSA
- First-generation cephalosporin (e.g., cefazolin) — alternative for MSSA
- Vancomycin — for penicillin allergy (type I), suspected or confirmed MRSA, or immunocompromised patients
- Note: Retrospective studies show higher relapse rates with vancomycin vs. β-lactam for non-MRSA infections; reserve vancomycin for true indications
- Ceftriaxone or third-generation cephalosporins — for gram-negative organisms (Enterobacteriaceae, Proteus, Serratia)
- Cefepime/ceftazidime + aminoglycoside or piperacillin-tazobactam + aminoglycoside × 2–4 weeks → then ciprofloxacin 750 mg PO q12h — for Pseudomonas aeruginosa
Table: Definitive Antibiotic Therapy for Osteomyelitis (Adults, No Implants) (Harrison's 22e, Table 136-1)
| Organism | IV Regimen | Oral Step-Down |
|---|
| MSSA | Nafcillin/oxacillin 2 g IV q6h | Rifampin 300–450 mg q12h + levofloxacin 750 mg q24h |
| MRSA | Vancomycin 15 mg/kg IV q12h or Daptomycin 8–10 mg/kg IV q24h | Rifampin + levofloxacin or TMP-SMX or fusidic acid |
| Streptococcus spp. | Penicillin G 5 MU IV q6h or Ceftriaxone 2 g IV q24h | — |
| Enterobacteriaceae (quinolone-susceptible) | Ciprofloxacin 750 mg PO q24h | — |
| Enterobacteriaceae (quinolone-resistant/ESBL) | Imipenem 500 mg IV q6h or Meropenem 1–2 g IV q8h | — |
| Pseudomonas aeruginosa | Cefepime/ceftazidime 2 g IV q8h + aminoglycoside × 2–4 wks | Ciprofloxacin 750 mg PO q12h |
| Anaerobes | Clindamycin 600 mg IV q6–8h × 2–4 wks | Clindamycin 300 mg PO q6h |
IV-to-oral switch: Early (within days) IV-to-oral step-down is safe in uncomplicated acute osteomyelitis in patients improving clinically and haematologically — Bailey & Love, 28e
Surgical Management — Acute
Surgery is reserved for:
- Failure to improve after 48–72 hours of antibiotics
- Draining an abscess or subperiosteal collection
- Decompression to prevent avascular necrosis of cortical bone
In children: Acute hematogenous osteomyelitis (AHO) can frequently be treated with antibiotics alone. Surgery is necessary when pus has collected or bone destruction is present.
Subacute Osteomyelitis (Brodie's Abscess)
- Localized radiolucency with sclerotic rim at the metaphysis of long bones
- Almost exclusively S. aureus (lower virulence)
- Treatment: Surgical debridement + 6 weeks IV antibiotics
- Important: Rule out chondroblastoma — "biopsy all infections, culture all tumors" — Miller's Review of Orthopaedics, 9e
Chronic Osteomyelitis
Surgery is required — medical-only management fails due to avascular sequestra that antibiotics cannot penetrate.
Surgical Principles
- Multiple/repeat procedures are frequently necessary
- Remove all infected hardware
- Remove dead bone (sequestrum) — acts as a foreign body
- Debridement until punctate bleeding is restored ("paprika sign")
- Debridement of compromised or necrotic soft tissue
- Preoperative sinus tract injection with methylene blue (to define extent)
- Consider antibiotic spacers: PMMA (polymethylmethacrylate) cement impregnated with antibiotics, or biologic spacers
- Restore vascularity and soft tissue/muscle coverage (plastic surgery input often required)
Medical Management — Chronic
- 6 weeks antibiotics directed at specific cultures (open bone biopsy is the best diagnostic test — sinus tract cultures are unreliable)
- Ensure adequate drug levels at the site of infection
- Treat underlying conditions: diabetes, malnutrition, vascular insufficiency, sickle cell disease
Vertebral Osteomyelitis (Spondylodiscitis)
- Also called: disk-space infection, septic diskitis, spondylodiskitis
- Most common form of hematogenous osteomyelitis in adults
- Primary foci: urinary tract, skin/soft tissue, IV catheter sites, endocardium
- MRI with gadolinium is the investigation of choice (shows decreased T1, increased STIR signal in vertebral bodies + disk space loss)
Treatment:
- IV antibiotics (organism-directed, 6 weeks)
- Image-guided CT aspiration/biopsy for organism identification
- CT/ultrasound-guided drainage of paraspinal/psoas abscesses
- Surgery is indicated for:
- Spinal instability
- Neurological deficits / spinal cord compression
- Failure to respond to antibiotics
- Epidural abscess requiring decompression
Osteomyelitis in Specific Populations
Children (Acute Hematogenous)
- Most common organism: S. aureus (MRSA is now most common in AHO)
- Male predominance (2:1 to 3:1); long bones ~80%
- Distal metaphysis is the predilection site (high vascularity)
- Blood cultures positive in ~40%; tissue cultures positive ~86%
- Often treatable with antibiotics alone — early IV then oral step-down
- Surgical drainage if abscess or failure to improve
Neonates
- Group B Streptococcus most common, followed by staphylococci
- Multiple sites involved in ~50%
- Radiographs often abnormal early; MRI if normal X-ray with high suspicion
- High risk of concurrent septic arthritis (vascular channels cross the physis)
Diabetic Foot Osteomyelitis
- Polymicrobial infection (gram-positive + gram-negative + anaerobes)
- Definitive care is usually surgical (debridement, revascularization, or amputation)
- Probe-to-bone test is a useful bedside test
- Prolonged oral fluoroquinolone therapy with anaerobic coverage is often used after surgery
Implant-Associated Osteomyelitis
- Even acute implant infection requires prolonged antimicrobial therapy
- Biofilm formation renders standard antibiotic courses insufficient
- Rifampin-based combinations are the cornerstone for staphylococcal implant infections
- Options: retain implant (DAIR — debridement, antibiotics, implant retention) vs. two-stage exchange
Supportive Measures
- Rest and splintage of the affected limb
- Adequate analgesia
- Nutritional support
- Optimise glycaemic control in diabetics
- Treat underlying conditions (sickle cell, immunodeficiency, malnutrition)
Complications
| Complication | Notes |
|---|
| Chronic osteomyelitis | Most common; involucrum/sequestrum formation |
| Sepsis / bacteraemia | Especially acute stage |
| Septic arthritis | Via contiguous spread or sympathetic effusion |
| Pathological fracture | Through area of bone destruction |
| Growth disturbance | In children — physeal damage → limb shortening/deformity |
| Spinal cord compression | In vertebral osteomyelitis |
| Malignant transformation | Squamous cell carcinoma in chronic sinus tracts (Marjolin's ulcer) |
| Amyloidosis | Rare — secondary to chronic infection |
Sources:
- Harrison's Principles of Internal Medicine, 22e — Classification & Antibiotic Therapy Table
- Rosen's Emergency Medicine, 9e — Clinical Features, Management, Antibiotic Regimens
- Bailey & Love's Short Practice of Surgery, 28e — Pathophysiology, Surgical Principles
- Miller's Review of Orthopaedics, 9e — Cierny-Mader Staging, Chronic OM Treatment
- Grainger & Allison's Diagnostic Radiology — Vertebral Osteomyelitis, Imaging-guided Treatment